Prm213 - Learnings From Consumer Research for Patient Preference Research

Abstract

OBJECTIVES: Although preference research originated in consumer market research, preference elicitation methods increasingly gained attention in healthcare over the last decade. Information on patients' perceptions and trade-offs can inform decision-making in different stages of the medicinal product life cycle. However, uncertainties regarding the application of preference methods in healthcare remain as it is not always clear how to adjust methods appropriately for elicitation of patient preferences. METHODS: A scoping review is performed to identify novel concepts on preference elicitation in consumer context, that may offer innovative applications in healthcare. The applicability is assessed by comparing with the current standards for patient preference methods, set by the Food and Drug Administration (FDA), the Medical Device Innovation Consortium (MDIC) and ISPOR Conjoint Analysis task forces. RESULTS: Five concepts are identified with promising value in healthcare: simulating alternatives, self-reflection, feedback-driven exploration, separated (adaptive) dual response and arranging profiles in blocks. The common thread between these concepts is the aim to resemble the real-life decision process of the patient as closely as possible, allowing to elicit 'true preferences'. The outcomes of preference studies adopting these concepts confirm that preference elicitation experiments that resemble the real-life situation, result in more accurate measurements. CONCLUSIONS: The process of acquiring information about new available products by consumers before deciding about buying a product, strongly resembles the process of patients familiarizing themselves with benefits and risks before deciding on their preferred treatment option. Meeting patients' informational needs and creating a real-life decision context wherein patients have time to self-reflect, could potentially improve preference elicitation in healthcare. OBJECTIVES:The objective of this study was to assess whether utility source references used in economic modelling for health technology assessment come from widely cited publications. METHODS: We reviewed The National Institute for Health and Care Excellence (NICE) technology appraisal documents and Evidence Review Group (ERG) comments for diseases across four therapeutic areas: oncology, cardiology, ophthalmology and mental health. Utility values used in manufacturer's submissions and ERG models were identified and corresponding references were extracted. The application of Publish or Perish was used to identify most commonly cited citations from Google Scholar. Different combinations of keywords were tested. Most commonly cited citations and utility references were compared. RESULTS: References from 8 documents were reviewed. In general, 65% (18/28) of the utility source references were among the mostly cited references (with minimum 20 citations): 91% (10/11) in the ophthalmology, 57% (4/7) in oncology, 50% (3/6) in mental health, and 25% (1/4) in cardiology. Our results have shown that most of util...

Demand preferences for health management services in a population of older adults with visual impairment in China: a conjoint analysis

“…By using a mathematical analysis method, value can be assigned to each attribute level to evaluate the utility and relative importance of a product or service, and ultimately assess the consumer preference. Conjoint analysis was originally used to study consumer preferences, but it has been widely studied in recent years, such as in public policy and healthcare [ 45 – 47 ]. Patients are a special consumer group and have special preferences for medical services.…”